Dr Richard Chadwick Blackford, PHD - Medicare Psychologist in Erie, PA

Dr Richard Chadwick Blackford, PHD is a medicare enrolled "Psychologist - Clinical" provider in Erie, Pennsylvania. He graduated from medical school in 1989 and has 35 years of diverse experience with area of expertise as Clinical Psychologist. He is a member of the group practice Richard C. Blackford, Ph.d. P.c. and his current practice location is 1444 W 38th St, Erie, Pennsylvania. You can reach out to his office (for appointments etc.) via phone at (814) 835-7043.

Dr Richard Chadwick Blackford is licensed to practice in Pennsylvania (license number PS-006224-L) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1053318360.

Contact Information

Dr Richard Chadwick Blackford, PHD
1444 W 38th St,
Erie, PA 16508-2346
(814) 835-7043
(814) 838-2925



Healthcare Provider's Profile

Full NameDr Richard Chadwick Blackford
GenderMale
SpecialityClinical Psychologist
Experience35 Years
Location1444 W 38th St, Erie, Pennsylvania
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Richard Chadwick Blackford graduated from medical school in 1989
  NPI Data:
  • NPI Number: 1053318360
  • Provider Enumeration Date: 06/30/2005
  • Last Update Date: 10/05/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 3678756269
  • Enrollment ID: I20110318000596

Medical Identifiers

Medical identifiers for Dr Richard Chadwick Blackford such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053318360NPI-NPPES
001560510MedicaidPA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103TC0700XPsychologist - Clinical PS-006224-L (Pennsylvania)Primary
103TC0700XPsychologist - Clinical PSY-11983 (California)Secondary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Richard C. Blackford, Ph.d. P.c.92344499762

News Archive

New approach may help researchers find new drugs for human diseases

A team of biochemists and mathematicians have developed a sophisticated geometric model to predict how a biological molecule will interact with water molecules, computing the results up to 20 times faster than other existing approaches. This new approach may help researchers find new drugs to treat human diseases, said the team, who described their theoretical approach in the Journal of Chemical Physics, which is produced by AIP Publishing.

Researchers identify target molecules for development of new allergy drugs

Researchers have identified several target molecules which are suitable for the development of new allergy drugs. The Journal of Allergy and Clinical Immunology, the most prestigious journal in the field of allergology, has recently published an extensive review article on the prospects of drug therapy for allergy. Completed in a large-scale EU project, the lead author of the review article is Professor Ilkka Harvima of the University of Eastern Finland and Kuopio University Hospital.

'Vaccine diplomacy' could reduce disease burden on Korean Peninsula

"North Korean leader Kim Jong Un, in a New Year's Day speech, called for reductions in international tension and an end to confrontation with South Korea, while raising the prospect of reunification between the North and South," Peter Hotez, president and director of the Sabin Vaccine Institute, notes in a Los Angeles Times opinion piece, asking, "Could 'vaccine diplomacy' work on the Korean peninsula?."

Inhibitor compounds could form basis of new treatments for such diseases as MRSA, anthrax

​Inhibitor compounds developed by UC Irvine structural biologists and Northwestern University chemists have been shown to bolster the ability of antibiotics to treat deadly bacterial diseases such as MRSA and anthrax.

Combination of broadly neutralizing antibodies can suppress virus in HIV-infected mice, study shows

Without antiretroviral drug treatment, the majority of people infected with HIV ultimately develop AIDS, as the virus changes and evolves beyond the body's ability to control it.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Richard Chadwick Blackford allows following entities to bill medicare on his behalf.
Entity NameRichard C. Blackford, Ph.d. P.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144615600
PECOS PAC ID: 9234449976
Enrollment ID: O20151109000300

News Archive

New approach may help researchers find new drugs for human diseases

A team of biochemists and mathematicians have developed a sophisticated geometric model to predict how a biological molecule will interact with water molecules, computing the results up to 20 times faster than other existing approaches. This new approach may help researchers find new drugs to treat human diseases, said the team, who described their theoretical approach in the Journal of Chemical Physics, which is produced by AIP Publishing.

Researchers identify target molecules for development of new allergy drugs

Researchers have identified several target molecules which are suitable for the development of new allergy drugs. The Journal of Allergy and Clinical Immunology, the most prestigious journal in the field of allergology, has recently published an extensive review article on the prospects of drug therapy for allergy. Completed in a large-scale EU project, the lead author of the review article is Professor Ilkka Harvima of the University of Eastern Finland and Kuopio University Hospital.

'Vaccine diplomacy' could reduce disease burden on Korean Peninsula

"North Korean leader Kim Jong Un, in a New Year's Day speech, called for reductions in international tension and an end to confrontation with South Korea, while raising the prospect of reunification between the North and South," Peter Hotez, president and director of the Sabin Vaccine Institute, notes in a Los Angeles Times opinion piece, asking, "Could 'vaccine diplomacy' work on the Korean peninsula?."

Inhibitor compounds could form basis of new treatments for such diseases as MRSA, anthrax

​Inhibitor compounds developed by UC Irvine structural biologists and Northwestern University chemists have been shown to bolster the ability of antibiotics to treat deadly bacterial diseases such as MRSA and anthrax.

Combination of broadly neutralizing antibodies can suppress virus in HIV-infected mice, study shows

Without antiretroviral drug treatment, the majority of people infected with HIV ultimately develop AIDS, as the virus changes and evolves beyond the body's ability to control it.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Richard Chadwick Blackford is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Richard Chadwick Blackford, PHD
1444 W 38th St,
Erie, PA 16508-2346

Ph: (814) 835-7043
Dr Richard Chadwick Blackford, PHD
1444 W 38th St,
Erie, PA 16508-2346

Ph: (814) 835-7043

News Archive

New approach may help researchers find new drugs for human diseases

A team of biochemists and mathematicians have developed a sophisticated geometric model to predict how a biological molecule will interact with water molecules, computing the results up to 20 times faster than other existing approaches. This new approach may help researchers find new drugs to treat human diseases, said the team, who described their theoretical approach in the Journal of Chemical Physics, which is produced by AIP Publishing.

Researchers identify target molecules for development of new allergy drugs

Researchers have identified several target molecules which are suitable for the development of new allergy drugs. The Journal of Allergy and Clinical Immunology, the most prestigious journal in the field of allergology, has recently published an extensive review article on the prospects of drug therapy for allergy. Completed in a large-scale EU project, the lead author of the review article is Professor Ilkka Harvima of the University of Eastern Finland and Kuopio University Hospital.

'Vaccine diplomacy' could reduce disease burden on Korean Peninsula

"North Korean leader Kim Jong Un, in a New Year's Day speech, called for reductions in international tension and an end to confrontation with South Korea, while raising the prospect of reunification between the North and South," Peter Hotez, president and director of the Sabin Vaccine Institute, notes in a Los Angeles Times opinion piece, asking, "Could 'vaccine diplomacy' work on the Korean peninsula?."

Inhibitor compounds could form basis of new treatments for such diseases as MRSA, anthrax

​Inhibitor compounds developed by UC Irvine structural biologists and Northwestern University chemists have been shown to bolster the ability of antibiotics to treat deadly bacterial diseases such as MRSA and anthrax.

Combination of broadly neutralizing antibodies can suppress virus in HIV-infected mice, study shows

Without antiretroviral drug treatment, the majority of people infected with HIV ultimately develop AIDS, as the virus changes and evolves beyond the body's ability to control it.

Read more News

› Verified 2 days ago


Psychologist in Erie, PA

Richard Allen Giacomelli, M.A.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 2820 W 21st St, Suite 5, Erie, PA 16506
Phone: 814-882-7650    
Michael Forrest Skarlinski, PH.D.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 4630 Buffalo Rd, Erie, PA 16510
Phone: 814-881-4404    
Mrs. Claire Donch, LCSW
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 301 West 10th Street, Erie, PA 16502
Phone: 814-455-4009    Fax: 814-455-7715
Susan Troutner,
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 120 E 2nd St, Third Floor, Erie, PA 16507
Phone: 814-877-8013    Fax: 814-877-8007
Susan A Moore-motily, MA
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 3939 W Ridge Rd, Ste A210, Erie, PA 16506
Phone: 814-838-9155    Fax: 814-838-9097
Anthony Gerard Bostaph, M.A.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 4402 Peach St, Lower Level/ North, Erie, PA 16509
Phone: 814-868-0141    Fax: 814-868-0142

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.